Transarterial Chemoembolisation Combined with Lenvatinib Plus Pembrolizumab Versus Dual Placebo for Unresectable, Non-Metastatic Hepatocellular Carcinoma (LEAP-012): a Multicentre, Randomised, Double-Blind, Phase 3 StudyMasatoshi Kudo,Zhenggang Ren,Yabing Guo,Guohong Han, Hailan Lin,Jinfang Zheng,Sadahisa Ogasawara,Ji Hoon Kim,Haitao Zhao,Chuan Li,David C. Madoff,R. Mark Ghobrial,Tomokazu Kawaoka,Masafumi Ikeda, Rene Gerolami,Hiromitsu Kumada,Anthony B. El-Khoueiry,Arndt Vogel, Xiang Peng,Kalgi Mody,Corina Dutcus,Leonid Dubrovsky,Abby B. Siegel,Richard S. Finn, Josep M. LlovetLANCET（2025）引用 1|浏览1AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
